SP362ERYTHROPOIETIN STIMULATING AGENTS AND RED CELL DISTRIBUTION WIDTH

Prognostic Validity of Red Cell Distribution Width in Neonatal Sepsis

Background Neonatal sepsis is one of the most critical illness in neonates that is responsible for a great proportion of morbidity and mortality in neonates so early diagnosis and identification of high risk cases is a challenging aim of our study. The purpose of this study was to investigate the prognostic value of red cell distribution width (RDW), in neonatal sepsis at the time of admission ...

Red Cell Distribution Width in Myocardial Infarction

Association between Red Cell Distribution Width and Mortality in Pediatric Patients Admitted to Intensive Care Units

Background: Red cell distribution width (RDW) is a routine laboratory measure that could be used as a predictor of mortality in critically ill patients. Identification of patients at risk for mortality early in the course of PICU admission is an important step in improving the outcome. We aimed to assess the use of RDW as an early biomarker for outcome in pediatric critical illnesses. Methods:...

Association between Red Cell Distribution Width and Hypertension in Tabari Cohort Population: A Case-control Study

 Background and purpose: Red Cell Distribution Width (RDW) is a parameter that measures changes in red blood cell size reported in a complete blood count test. In this study, we aimed to identify the association between RDW and hypertension in Tabari cohort population. Materials and methods: In this case-control study, case group included all patients with hypertension (n= 2281) participating ...

Red cell distribution width in sickle cell disease.

Red cell distribution width (RDW), an electronically determined index of anisocytosis, was examined in 60 patients with sickle cell anemia (Hb SS), 28 patients with hemoglobin sickle cell (SC) disease, and seven patients with sickle cell-beta(+) thalassemia (S-thal). All patients were adults and in the steady state of their disease. The RDW was greater in sickle cell patients than in 39 healthy...